School of Chemistry

Image of Christopher Moody

Christopher Moody

Professor of Organic Chemistry (Emeritus),



Chris Moody is now Professor Emeritus in Chemistry at the University of Nottingham. From 2005 to 2020 he was the Sir Jesse Boot Professor of Chemistry at Nottingham. He is a Mancunian and was educated at Manchester Grammar School and King's College, London, before carrying out his PhD research at the University of Liverpool under the supervision of Charles Rees investigating the synthesis and reactions of nitrogen-sulfur ylides. He spent a postdoctoral year at the ETH in Zürich working with Albert Eschenmoser on the stereochemistry of 1,4-elimination reactions before taking up a post in industry at Roche. In 1979 he was appointed to a lectureship at Imperial College, London, and was promoted to a readership in 1989. In 1990 moved to the chair of organic chemistry at Loughborough University, and in 1996 he was appointed Professor of Organic Chemistry at the University of Exeter.

He has published over 440 papers and his work has been recognised with several awards including the RSC Hickinbottom Fellowship and Corday Morgan Medal (both in 1986), the Tilden Medal and Lectureship (2000-2001), the Adrien Albert Medal and Lectureship (2001), an EPSRC Senior Research Fellowship (2000-2005), the Royal Society of Chemistry Award for Synthetic Organic Chemistry (2006), the Pedler Lectureship (2008), the Novartis International Lectureship (2010-2011), and the Royal Society of Chemistry Charles Rees Award (2012).

After retiring from the Sir Jesse Boot Chair, he co-founded Alevin Therapeutics Ltd, a university spinout company aiming to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies.

Recent Publications

  • K. BOUZINAB, H. S. SUMMERS, M. F. G. STEVENS, C. J. MOODY, N. R. THOMAS, P. GERSHKOVICH, N. WESTON, M. B. ASHFORD, T. D. BRADSHAW and L. TURYANSKA, 2020. Delivery of temozolomide and N3-propargyl analog to brain tumors using an apoferritin nanocage: ACS Appl. Mater. Interfaces ACS Appl. Mater. Interfaces. 12, 12609-12617
  • H. S. SUMMERS, M. B. FOREITER, W. LEWIS, C. J. MOODY, T. D. BRADSHAW and M. F. G. STEVENS, 2020. Modulation of the acidity of the 8-carboxamide group in the temozolomide family of antitumour imidazo[5,1-d]-1,2,3,5-tetrazines: Arkivoc Arkivoc. 36-45
  • ROBINSON, H., OATLEY, S. A., ROWEDDER, J. E., SLADE, P., MACDONALD, S. J. F., ARGENT, S. P., HIRST, J. D., MCINALLY, T. and MOODY, C. J., 2020. Late-Stage Functionalization by Chan-Lam Amination: Rapid Access to Potent and Selective Integrin Inhibitors: Chemistry-a European Journal Chemistry-a European Journal. 26(34), 7678-7684
  • K. BOUZINAB, H. SUMMERS, J. ZHANG, M. F. G. STEVENS, C. J. MOODY, L. TURYANSKA, N. R. THOMAS, P. GERSHKOVICH, M. B. ASHFORD, E. VITTERSO, L. C. D. STORER, R. GRUNDY and T. D. BRADSHAW, 2019. In search of effective therapies to overcome resistance to temozolomide in brain tumours: Cancer Drug Resist. Cancer Drug Resist.. 2, 1018-1031

School of Chemistry

University Park Nottingham, NG7 2RD

For all enquiries please visit: